by admin | May 4, 2024 | Article
March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...
by admin | May 4, 2024 | Article
February 15, 2024 – Lupus Canada is honoured to be a member of the CIAN group. Together our goal is to protect more Canadians to improve the quality of life and significantly reduce hospitalization for vulnerable people. On page 60 of the Heal Canada Digital...
by admin | Apr 22, 2024 | Article
This is an anxious time across Canada and all over the world; keep in mind that most people who become infected have mild or even no symptoms. The main goal of all current recommendations is to slow the spread of the virus. People with lupus may ask: What precautions...
by admin | Apr 22, 2024 | Article
March 23, 2020 – Lupus Canada and the Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS) are calling on the Government of Canada to ensure critical supply of hydroxychloroquine for Canadians living with lupus. “Like all Canadians, we are...
by admin | Apr 22, 2024 | Article
We’ve heard you – Canadians living with lupus are having problems filling their prescriptions of hydroxychloroquine. Take a read of the issue in CTV’s article and spread the word....
